This website uses cookies

We use cookies to enhance your experience and support COUNTER Metrics for transparent reporting of readership statistics. Cookie data is not sold to third parties or used for marketing purposes.

Skip to main content
null
prnano
  • Menu
  • Articles
    • Case study
    • Communication
    • Editorial
    • Editorial Policies
    • Expression of concern
    • Letters to the Editor
    • Perspective, Opinion, or Discussion
    • Research Article
    • Review
    • Technical Note
    • All
  • For Authors
  • Editorial Board
  • About
  • Issues
  • Blog
  • The Rising Talents List
  • Journal Policies
  • search
  • Facebook (opens in a new tab)
  • LinkedIn (opens in a new tab)
  • RSS feed (opens a modal with a link to feed)

RSS Feed

Enter the URL below into your favorite RSS reader.

http://localhost:51057/feed
ISSN 2639-9431
Research Article
September 17, 2025 EDT

Development and Characterization of Bromocriptine Mesylate Loaded Nanostructured Lipid Carriers for Enhanced Nose-to-Brain Delivery

Darshan KA, M.Pharm, Anita R Desai, M.Pharm.,Ph.D, Mallappa Shalavadi, M.Pharm.,Ph.D, Basavaraj S. Nainegali, BE, M.Tech, Ph.D., Laxman S Vijapur, M.Pharm.,Ph.D,
Bromocriptine Mesylateintranasal drug deliveryParkinson's diseasePDNLCsLipidNanostructured lipid carriersintranasalDrug delivery
Copyright Logoccby-nc-4.0 • https://doi.org/10.33218/001c.144483
prnano
KA, Darshan, Anita R Desai, Mallappa Shalavadi, Basavaraj S. Nainegali, and Laxman S Vijapur. 2025. “Development and Characterization of Bromocriptine Mesylate Loaded Nanostructured Lipid Carriers for Enhanced Nose-to-Brain Delivery.” Precision Nanomedicine, September, 1586–1603. https:/​/​doi.org/​10.33218/​001c.144483.

View more stats

Powered by Scholastica, the modern academic journal management system